Mineralys Therapeutics Inc (MLYS) Stock Price

26.89 ▼ -2.51 (-8.54%)
Open: 29.36 Vol: 1.48M Day's range: 26.62 - 29.83 Sep 23, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MLYS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 26.98▼ 26.90▼ 26.90▼ 28.12▼ 27.38▼
MA10 26.95▼ 27.07▼ 27.99▼ 28.35▼ 26.78▲
MA20 26.90▼ 28.15▼ 28.27▼ 27.97▼ 26.92▼
MA50 26.97▼ 28.20▼ 28.20▼ 27.15▼ 30.54▼
MA100 28.00▼ 28.26▼ 28.78▼ 27.29▼ 23.36▲
MA200 28.33▼ 28.64▼ 27.36▼ 28.84▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.024▲ -0.177▼ -0.251▼ -0.123▼ 0.246▲
RSI 45.602▼ 30.174▼ 32.685▼ 45.837▼ 48.307▼
STOCH 67.563     9.194▼ 5.161▼ 21.050     33.096    
WILL %R -61.765     -92.880▼ -92.880▼ -94.972▼ -68.182    
CCI -16.993     -56.430     -97.002     -93.445     47.296    
Latest Filters Detected On MLYS
RSI $MLYS RSI(14) Crossed Below 50 Set Alert
▼ MACD $MLYS MACD(12,26,9) Crossed Below Signal Line Set Alert
MA $MLYS Price Crossed Below MA(200) Set Alert
MA $MLYS Price Crossed Below MA(50) Set Alert
MA $MLYS Price Crossed Below MA(26) Set Alert
MA $MLYS Price Crossed Below MA(13) Set Alert
MA $MLYS Price Crossed Below MA(7) Set Alert
▼ BREAK $MLYS Price Breaks 10 Days Low Set Alert
Mineralys Therapeutics Inc News
Mineralys Therapeutics’ Transform-HTN Open-Label Extension Trial Data Selected for Late-Breaking Presentation at American Heart Association Scientific Sessions 2026
Wednesday, September 23, 2026 09:05 AM
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as ...
Cours Mineralys Therapeutics, Inc.
Wednesday, September 23, 2026 12:59 AM
Mineralys Therapeutics, Inc.: Cours de bourse, graphiques, cotations, conseils boursiers, données financières, analyses et actualités en temps réel Action Mineralys Therapeutics, Inc. | MLYS | US60317 ...
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Monday, September 21, 2026 12:59 AM
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as ...
MLYS historical stock data
date open high low close volume
23/09/26 29.36 29.83 26.62 26.89 1,478,025
22/09/26 28.63 29.55 28.37 29.40 837,803
21/09/26 28.19 28.44 27.90 28.31 701,824
18/09/26 27.77 28.13 27.38 28.02 3,786,986
17/09/26 27.95 29.52 27.93 27.98 1,134,771
16/09/26 28.98 29.085 27.33 27.54 1,405,288
15/09/26 28.58 28.985 27.55 28.91 1,781,062
14/09/26 28.14 29.61 27.89 28.95 1,178,367
11/09/26 29.65 29.945 28.17 28.20 1,723,978
10/09/26 30.04 30.57 29.20 29.30 763,763
Quote Details
52wk Low:22.30
52wk High:47.65
Vol:1.48M
Avg Vol(3m):19.1M
1Y Chng:-31.73%
1M Chng:-0.59%
Add to Watch List
More Information
Index US Composite
Market Cap. 2.60B